What butyrate and short-chain fatty acids do

If you want to understand the function of your gut microbiota, butyrate, acetate and propionate provide information about part of its metabolic activity. They are produced during microbial fermentation and can be measured through metabolomics, although their interpretation depends on the method and the clinical context.

In summary:

• Butyrate, acetate and propionate are metabolites produced mainly when dietary components are fermented in the gut.
• Butyrate may contribute to maintaining the intestinal epithelium and to immune regulation, but it does not assess gut health on its own.
• Sequencing identifies microorganisms; it does not show how much of these metabolites they are producing.
• Functional short-chain fatty acid metabolomics makes it possible to study this activity, with limitations linked to the sample and the analysis.

Reviews in Nature Reviews Microbiology (2025) and Nature Reviews Immunology (2024) support this framework, but they do not turn an isolated result into a diagnosis.

What are butyrate and short-chain fatty acids?

Butyrate, acetate and propionate are short-chain fatty acids: molecules produced largely when gut microorganisms ferment fibre and other carbohydrates that are not fully absorbed in the small intestine. This is why they are considered functional metabolites of the gut microbiota (Nature Reviews Microbiology, 2025).

They are not bacteria, but products of bacterial activity. Acetate, propionate and butyrate can originate through different metabolic pathways and serve as substrates for other microorganisms or for the body’s cells. Their production depends on the available substrates and on the composition and activity of the microbial community (Nature Reviews Immunology, 2024).

That is why a gut microbiota analysis and the measurement of these metabolites answer different questions: one mainly describes which microorganisms are present, while the other provides information about some of what the microbial community is producing.

What roles can butyrate play in the gut?

Butyrate can serve as an energy substrate for colon cells and may be involved in mechanisms related to the gut barrier and immune regulation. However, measuring it alone does not confirm a disease or predict a clinical outcome in a specific person (Nature Reviews Microbiology, 2025; Nature Reviews Immunology, 2024).

The available reviews describe several areas of research:

• Colon cells can use butyrate as an energy source.
• It may be involved in mechanisms that help maintain intestinal epithelial function.
• It participates in signalling between the microbiota, intestinal cells and the immune system.
• Its effects depend on its concentration, the intestinal environment and the person’s physiological state.

These functions have been studied using cell and animal models, as well as studies in people, but the mechanisms observed do not automatically translate into a clinical benefit. For this reason, butyrate should be interpreted alongside symptoms, medical history and other tests. The prueba de zonulina addresses a different aspect: the assessment of intestinal permeability, not the direct measurement of this metabolite.

What is the difference between analysing the microbiota and measuring its metabolites?

Microbiota analysis describes which microorganisms or microbial groups are present, whereas metabolite measurement assesses part of the chemical activity associated with them in a specific sample. Both approaches therefore provide complementary information, but neither replaces clinical assessment on its own (Nature Reviews Microbiology review, 2025).

Sequencing can identify microorganisms or genes related to metabolic pathways, but it does not confirm how much butyrate each species is producing at that particular time. Production depends, among other factors, on the available substrates, interactions between microorganisms and conditions in the gut (Nature Reviews Immunology, 2024).

Therefore, a potentially butyrate-producing microorganism is not equivalent to a measured butyrate concentration. To complement information about which microorganisms are present, you can consult a gut microbiota analysis and consider functional measurement according to the clinical objective.

How is butyrate measured, and what can affect the result?

Butyrate and other short-chain fatty acids can be measured in biological samples, such as stool, using metabolomics techniques, often alongside acetate and propionate. However, the result depends on the type of sample, the analytical method, sample collection and storage, and the person’s clinical context (Nature Reviews Microbiology, 2025; Nature Reviews Immunology, 2024).

Chromatography and other separation and detection techniques can be used to quantify these metabolites, although results are not necessarily interchangeable across methods. Recent diet, intestinal transit, medication and supplements can alter microbial activity and the concentration observed. Sample collection, storage and transport also matter. For this reason, the laboratory’s instructions should be followed, and relevant factors should be discussed with the healthcare professional. In clinical practice, the access for healthcare professionals provides information about the applicable process.

What does a high or low butyrate result mean?

A high or low butyrate value does not have a universal meaning on its own: interpreting it requires knowing the sample analysed, the method used and its reference ranges, as well as considering symptoms, diet, medical history and other tests.

The concentration observed may depend on how the sample was collected and processed, so results generated using different methods or reference ranges should not be compared. The Nature Reviews Microbiology review (2025) highlights that measuring short-chain fatty acids requires both the analytical and biological context to be taken into account (study on short-chain fatty acids and health).

A low result does not, on its own, demonstrate a specific alteration in the microbiota, and a high result does not confirm better gut health either. The associations described between butyrate, diet, the microbiota and immunity do not automatically imply causality or allow an individual diagnosis to be established (review on short-chain fatty acids, the microbiome and immunity).

To put a report into context, a healthcare professional can use Sophia, the clinical AI, without replacing a clinical assessment.

Frequently asked questions

Is butyrate a bacterium?

No. Butyrate is a metabolite, meaning a molecule produced during certain chemical reactions in the gut microbiota. Some bacteria can generate butyrate by fermenting components of the diet, but detecting microorganisms with this potential capacity does not show how much butyrate is being produced in a specific person. This distinction is explained in reviews published in Nature Reviews Microbiology (2025) and Nature Reviews Immunology (2024).

Does a high-fibre diet always increase butyrate?

Not necessarily. Fibre can provide substrates for microbial fermentation and support the production of short-chain fatty acids, but the response depends on the type of fibre, the microbiota present, intestinal transit and other individual factors. For this reason, dietary advice should be adapted to the clinical context and should not be based solely on a single metabolite. (Nature Reviews Immunology, 2024).

Can a butyrate test diagnose dysbiosis?

No. Measuring butyrate provides information about a metabolite in a specific sample, but it does not by itself establish a diagnosis of dysbiosis, intestinal inflammation or another disease. Interpretation requires the analytical method, its reference intervals, symptoms, medical history and, where appropriate, other tests requested by a healthcare professional.

What is the difference between detecting butyrate producers and demonstrating that they produce butyrate?

Detecting microorganisms that are potentially capable of producing butyrate indicates that groups with a described metabolic capacity are present, but it does not confirm that they are active or the amount generated at that time. Production depends, among other factors, on the available substrates and microbial interactions. This is why sequencing and metabolite measurement provide complementary information. (Nature Reviews Microbiology, 2025).

Which professional should interpret an intestinal metabolomics result?

It should be interpreted by a healthcare professional with clinical training and knowledge of microbiota and laboratory testing. The result requires assessment of the sample, methodology, reference intervals and each person’s individual situation. It can help inform clinical questions or decisions, but it does not replace the medical history, physical examination or other tests indicated when necessary.

Learn about the functional metabolomics analysis to assess butyrate and other short-chain fatty acids.

Sources

• Gut microbiota-derived short-chain fatty acids and their role in human health and disease — Nature Reviews Microbiology — 2025-05-13
• Short-chain fatty acids: linking diet, the microbiome and immunity — Nature Reviews Immunology — 2024-04-02